Cargando…
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()
Autores principales: | Abrouk, Michael, Beroukhim, Kourosh, Nakamura, Mio, Zhu, Tian Hao, Farahnik, Benjamin, Singh, Rasnik, Brodsky, Merrick, Lee, Kristina, Koo, John, Bhutani, Tina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412117/ https://www.ncbi.nlm.nih.gov/pubmed/28492009 http://dx.doi.org/10.1016/j.ijwd.2016.02.001 |
Ejemplares similares
-
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()()
por: Abrouk, Michael, et al.
Publicado: (2017) -
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
por: Abrouk, Michael, et al.
Publicado: (2016)